Hugo robotic-assisted surgery (RAS) system capabilities for gynecologic, general, and urologic procedures in Europe.

As the first-ever robotic-driven LigaSure™ instrument, this milestone represents the beginning of a new era for the vessel-sealing technology that has been used in more than 35 million procedures across 65+ countries over the last two decades.

“Today, with CE Mark for LigaSure™ RAS, Medtronic is fulfilling a promise to customers to integrate our trusted vessel-sealing technology onto the Hugo™ RAS system,” said Matt Anderson, senior vice president and president of the Surgical business, which is part of the Medical Surgical Portfolio at Medtronic. “More than fulfilling a commitment, this regulatory approval is a big step forward as we continue to shape the future of surgery with surgical teams who share our passion and commitment to deliver the best possible care to every patient.”

Dr. Miguel Caceres of Pacifica Salud Hospital in Panama was one of the first surgeons in the world to use LigaSure™ RAS with the Hugo™ RAS system.

Powered by the Valleylab™ FT10 energy platform and for use exclusively with the Hugo™ RAS system, the LigaSure™ RAS Maryland instrument is indicated for sealing and cutting vessels, thick tissue, and lymphatics up to and including 7 mm in diameter. The device reliably seals vessels in approximately 2 seconds while minimizing thermal spread to surrounding tissue.

This week at SRS: LigaSure™ RAS initial experience, Hugo™ GYN data and telesurgery demo

Dr. Caceres, who has been using the Hugo™ RAS system four years, will discuss his initial experience with LigaSure™ RAS during a Medtronic-sponsored symposium at the Society of Robotic Surgery (SRS) 2025 Annual Meeting, July 16-20 in Strasbourg, France.